Browsing Tag
TL1A antibody development
1 post
AbbVie, FutureGen joins forces to pioneer next-gen IBD treatment FG-M701
In a significant development in the pharmaceutical industry, AbbVie Inc. (NYSE: ABBV) and FutureGen Biopharmaceutical (Beijing) Co., Ltd.…